← Back to Search

Behavioral Intervention

Personalized Reminders for Flu Vaccination

N/A

Recruiting

Led By Christopher F Chabris, PhD

Research Sponsored by Geisinger Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Has a health maintenance modifier indicating they are permanently discontinued from receiving a seasonal flu shot

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 4 months after randomization

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to see if personalized text messages can encourage more people to get a flu vaccine compared to generic messages or no messages at all."

Who is the study for?

This trial is for adults over 18 who have a Geisinger primary care provider and haven't had their flu shot for the year according to records. They must also have an upcoming non-urgent, in-person appointment scheduled with enough time to be included in the study.

What is being tested?

The study aims to see if personalized reminders about getting a flu vaccine are more effective than generic reminders or no reminders at all. Participants will receive different types of messages nudging them to get vaccinated.

What are the potential side effects?

Since this trial involves sending reminder messages rather than medical interventions, there are no direct side effects from participating. However, any decision following these nudges, like getting a flu shot, may carry typical vaccination side effects.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am advised against getting flu shots permanently.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 4 months after randomization

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 4 months after randomization

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 4 months after randomization for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number of Patients With Flu Shot Receipt Between Enrollment Date and Target Appointment Date

Other study objectives

Number of Patients With Flu Shot Receipt On or Before December 31, 2024

Number of Patients with Flu Diagnosis (encounter diagnosis or flu test)

Number of Patients with Flu Shot Receipt Between Enrollment Date and First Eligible Appointment

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: Personalized NudgeExperimental Treatment1 Intervention

Patients will receive the nudge predicted to be most effective for them on the basis of the machine learning-derived treatment assignment trees.

Group II: Best NudgeExperimental Treatment1 Intervention

Patients will receive the nudge found to be numerically most effective in the megastudy, including language that a flu vaccine is "reserved" for them at their upcoming appointment.

Group III: Active ControlExperimental Treatment1 Intervention

Patients will receive a simple message encouraging them to get a flu shot at their appointment.

Group IV: Passive ControlActive Control1 Intervention

Patients randomized to this arm will receive no special communications, beyond what Geisinger sends out as standard practice.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Reminder

2023

Completed Early Phase 1

~311310